(Q44138634)

30 November 2017

title

Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine (English)

1 reference

30 November 2017

1 reference

Alexandros Sotiriadis

1

1 reference

30 November 2017

Themistoklis Dagklis

2

1 reference

30 November 2017

Vaia Siamanta

3

1 reference

30 November 2017

Konstantinos Chatzigeorgiou

4

1 reference

30 November 2017

Theodoros Agorastos

5

1 reference

30 November 2017

LYSISTRATA Study Group

6

1 reference

30 November 2017

publication date

14 January 2012

1 reference

Archives of Gynecology and Obstetrics

30 November 2017

published in

1 reference

30 November 2017

volume

285

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

1719-1724

1 reference

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Evaluation of screening programmes for gynaecological cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Worldwide burden of cervical cancer in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Geographic disparity, area poverty, and human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Human papillomavirus vaccine among adult women: disparities in awareness and acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Factors influencing familial decision-making regarding human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Attitudes, intentions, and perceived barriers to human papillomavirus vaccination among Korean high school girls and their mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Worsening disparities in HPV vaccine utilization among 19-26 year old women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005-2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

The HPV vaccine: a content analysis of online news stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

An analysis of the Human Papilloma Virus vaccine debate on MySpace blogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-011-2208-Z

10.1007/S00404-011-2208-Z

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference